VERY Impressive - not only does this 1) support the ongoing development of ATL1103 for its intended application, it also ii) opens a new dorr to cancer treatment application - perhaps this has been previously publicly floated, I don't know?
However, iii) is the real positive, drugs that show a material enhancement to the fighting of cancers have an excellent - **excellent** - "chance" (read expectation) to receiving fast-track (breakthrough) USFDA recognition. A drug that does two wonder tricks, well..... ;) (breakthrough with a VERY Big B).
Go..Go...GO ATP!!!! Happy weekend to all!
(Ps. good news week it seems for Aussie cancer breakthroughs with QBiotics and all)
off we go!, page-25
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
-0.002(2.44%) |
Mkt cap ! $84.79M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.3¢ | 7.9¢ | $287.6K | 3.558M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 939854 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 277962 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |